Ventyx Biosciences, Inc.

Historical 13F Holders

Symbol
VTYX
CUSIP
92332V107
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 92332V107 since 12/18/2024, largest first.

Filer % of Class Filed
NSV Investments I, L.P. 13D/A
7.6% 3/12/2025
Event 3/10/2025
Raju Mohan 13D/A 6.0% 1/9/2026
Event 1/7/2026
NSV Partners III LP 13D/A
5.7% 4/1/2025
Event 3/28/2025
Vanguard Group Inc 13G 5.3% 10/31/2025
Event 9/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (11)
Point72 Asset Management, L.P. 13G/A
4.5% 11/14/2025
Event 9/30/2025
Sio Capital Management, LLC 13G/A 3.6% 4/8/2025
Event 3/31/2025
Citadel Advisors LLC 13G/A
2.0% 5/15/2025
Event 3/31/2025
BlackRock, Inc. 13G/A 1.9% 7/16/2025
Event 6/30/2025
Bank of America Corp /DE/ 13G/A 1.4% 5/15/2025
Event 3/31/2025
James E. Flynn 13G/A
0.8% 2/13/2025
Event 12/31/2024
Morgan Stanley 13G/A 0.3% 2/6/2026
Event 1/31/2026
Affinity Asset Advisors, LLC 13G/A
0% 5/14/2026
Event 3/31/2026
Glazer Capital, LLC 13G/A
0% 5/14/2026
Event 3/31/2026
Subramaniam Somu 13D/A 0% 3/5/2026
Event 3/4/2026
Tang Capital Management LLC 13G/A
0% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q1 1 1.50 k $21.0k
2025 Q4 140 52.2 M $472M
2025 Q3 110 43.9 M $136M
2025 Q2 115 44.4 M $95.1M
2025 Q1 117 44.4 M $51.1M
2024 Q4 125 54.4 M $119M
2024 Q3 119 52.5 M $114M
2024 Q2 118 57.3 M $132M
2024 Q1 127 59.0 M $324M
2023 Q4 124 43.3 M $107M
2023 Q3 146 54.6 M $1.90B
2023 Q2 155 52.7 M $1.73B
2023 Q1 150 49.7 M $1.67B
2022 Q4 130 42.7 M $1.40B
2022 Q3 106 39.3 M $1.37B
2022 Q2 64 34.6 M $424M
2022 Q1 56 33.2 M $448M
2021 Q4 47 31.6 M $619M